Vena cava filters in hospitalised patients with chronic obstructive pulmonary disease and pulmonary embolism

Journal: Thrombosis and Haemostasis
ISSN: 0340-6245

Theme Issue
High on-treatment platelet reactivity

Issue: 2013: 109/5(May) pp. 769-975
Pages: 897-900
Ahead of Print: ###MANUSCRIPT_aheadofprint###

Vena cava filters in hospitalised patients with chronic obstructive pulmonary disease and pulmonary embolism

P. D. Stein (1), F. Matta (1, 2)

(1) Department of Osteopathic Medical Specialties, Michigan State University College of Osteopathic Medicine, East Lansing, Michigan, USA; (2) Department of Research, St. Mary Mercy Hospital, Livonia, Michigan, USA


pulmonary embolism, venous thromboembolism, chronic obstructive pulmonary disease, vena cava filters


In view of the high case fatality rates of patients with chronic obstructive pulmonary disease (COPD) who have pulmonary embolism (PE) we speculated that such patients might benefit from vena cava filters. To test this hypothesis we assessed the database of the Nationwide Inpatient Sample. From 1998–2009, 440,370 patients were hospitalised with PE and COPD who were not in shock or ventilator-dependent and did not receive thrombolytic therapy or pulmonary embolectomy. In-hospital all-cause case fatality rate among those with filters was 5,890 of 68,800 (8.6%) (95% confidence interval [CI] = 8.4–8.8) compared with 38,960 of 371,570 (10.5%) (95% CI = 10.4–10.6) (p<0.0001) who did not receive filters. Case fatality rate was age-dependent. Only those who were older than aged 50 years had a lower in-hospital all-cause case fatality rate with filters. Among such patients, absolute risk reduction was 2.1% (95% CI = 1.9–2.3). The greatest reduction of case fatality rate with vena cava filters was shown in patients >aged 80 years, 11,720 of 81,600 (14.4%) compared with 1,570 of 17,220 (9.1%) (p<0.0001). In conclusion, a somewhat lower in-hospital all-cause case fatality rate was shown with vena filters in stable patients with PE >aged 50 years who also had COPD. The benefit was greatest in elderly patients. The benefit in terms of a decreased case fatality rate would seem to outweigh the risks of vena cava filters in such patients.

You may also be interested in...

H. Leon Daneschvar1, Ali Seddighzadeh1, Gregory Piazza2, Samuel Z. Goldhaber1

Thromb Haemost 2008 99 6: 1035-1039

S. L. Schulz1, B. Stechemesser2, U. Seeberger1, S. Müller1, D. Andresen1, U. Baer2

Phlebologie 2008 37 2: 61-67

Cihan Ay1,*, Lea V. Jungbauer2,*, Alexandra Kaider3, Silvia Koder1, Simon Panzer4, Ingrid Pabinger1, Christine Mannhalter2

Thromb Haemost 2008 99 5: 899-904

Thrombosis News

Mobile technology identifies people with unknown atrial fibrillation at high risk of stroke – article published in Thrombosis and Haemostasis

The article “Feasibility and cost effectiveness of stroke prevention through community screening...

TH 111.4

The April 2014 TH 111.4 issue of Thrombosis and Haemostasis is a Theme Issue by Guest Editor B....

TH 111.3

Women with atrial fibrillation have a much higher risk for thromboembolic stroke than men suffering...